Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00700973 · ClinicalTrials.gov registry record · Phase 2
Treating Violence-Prone Substance Use Disorder Patients
A Phase 2 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
- 141
- Enrollment target
NCT00700973: Completed Phase 2 study, sponsored by US Department of Veterans Affairs.
NCT00700973 is a Phase 2 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 141 participants, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00700973, a Phase 2 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 141 participants
- Enrollment target
Study Summary
This project is intended to help substance use disorder patients who perpetrate interpersonal violence against other adults.
Primary Outcome
Scores range from 0 to 1, with higher scores indicating more severe legal problems.
Interventions
- OTHER Usual care
- BEHAVIORAL Interpersonal Violence Prevention Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2009-02 |
| Est. Completion | 2013-11 |
| Phase | Phase 2 |
What the finished NCT00700973 record still lists
NCT00700973 is an interventional study that assigns participants to a tested intervention. The registered 141 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which Usual care is the first listed.
NCT00700973 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00700973 about?
NCT00700973 is a clinical study titled "Treating Violence-Prone Substance Use Disorder Patients". This project is intended to help substance use disorder patients who perpetrate interpersonal violence against other adults.
What is the current status of trial NCT00700973?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 141 participants. The study started on 2009-02. Estimated completion is 2013-11.
What interventions are being tested in trial NCT00700973?
The interventions under investigation include: Usual care (OTHER), Interpersonal Violence Prevention Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00700973?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00700973's enrollment target sits among peer trials
141 510th of 2000 higher than 1,489 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03042962 · 141 participants
Brain Networks in Dystonia
- NCT04378439 · 141 participants · NA
Appalachian Partnership to Reduce Disparities (Aim 2)
- NCT04775485 · 141 participants · Phase 2
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
- NCT05040360 · 141 participants · Phase 2
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia